Morphic Holding Financials

Morphic Holding Stock Summary

Morphic Holding competes with Arcellx, Ventyx Biosciences, Immunocore Holdings, Vaxcyte, and 89bio. Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.

Morphic Holding Key Financial Ratios

Morphic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Morphic Holding's current stock value. Our valuation model uses many indicators to compare Morphic Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Morphic Holding competition to find correlations between indicators driving Morphic Holding's intrinsic value. More Info.Morphic Holding is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Morphic Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Morphic Holding Market Pulse

Along with financial statement analysis, the daily predictive indicators of Morphic Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Morphic Holding. We use our internally-developed statistical techniques to arrive at the intrinsic value of Morphic Holding based on widely used predictive technical indicators. In general, we focus on analyzing Morphic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Morphic Holding's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.